111 related articles for article (PubMed ID: 38801972)
1. Genistein-Chitosan Derivative Nanoparticles for Targeting and Enhancing the Anti-Breast Cancer Effect of Tamoxifen In Vitro.
Xing Y; Shen W; Sun C; Wang R; Fan B; Liang G
J Pharm Sci; 2024 May; ():. PubMed ID: 38801972
[TBL] [Abstract][Full Text] [Related]
2. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.
Pons DG; Nadal-Serrano M; Torrens-Mas M; Oliver J; Roca P
J Cell Biochem; 2016 Jan; 117(1):218-29. PubMed ID: 26100284
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
Nokhodi F; Nekoei M; Goodarzi MT
J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166
[TBL] [Abstract][Full Text] [Related]
5. Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells.
Mai Z; Blackburn GL; Zhou JR
Mol Carcinog; 2007 Jul; 46(7):534-42. PubMed ID: 17295235
[TBL] [Abstract][Full Text] [Related]
6. [Reversal effect of peptide-modified chitosan tetramethylpyrazine nanoparticles on multidrug resistance in tumor cells].
Xiang-Yang L; Qing F; Chen-Yang Z; Ming-Kun S; Hui MA; Li-Chun C; Ren Bao Li Gao A; Zhen-Long YU
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5487-5494. PubMed ID: 33350210
[TBL] [Abstract][Full Text] [Related]
7. PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells.
Fahmy SA; Ramzy A; Mandour AA; Nasr S; Abdelnaser A; Bakowsky U; Azzazy HME
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214139
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three water-soluble polyphosphate tripolyphosphate, phytic acid, and sodium hexametaphosphate as crosslinking agents in chitosan nanoparticle formulation.
Sang Z; Qian J; Han J; Deng X; Shen J; Li G; Xie Y
Carbohydr Polym; 2020 Feb; 230():115577. PubMed ID: 31887915
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of PLGA-PEG-PLGA Nanoparticles Containing Salidroside and Tamoxifen for Breast Cancer Therapy.
Yu X; Sun L; Tan L; Wang M; Ren X; Pi J; Jiang M; Li N
AAPS PharmSciTech; 2020 Jan; 21(3):85. PubMed ID: 31997020
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting.
Patil PB; Patel JK
Breast Cancer; 2023 Nov; 30(6):1065-1078. PubMed ID: 37695494
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Cirpanli Y; Yerlikaya F; Ozturk K; Erdogar N; Launay M; Gegu C; Leturgez T; Bilensoy E; Calis S; Capan Y
Pharmazie; 2010 Dec; 65(12):867-70. PubMed ID: 21284254
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity Enhancement in MCF-7 Breast Cancer Cells with Depolymerized Chitosan Delivery of α-Mangostin.
Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M
Polymers (Basel); 2022 Aug; 14(15):. PubMed ID: 35956654
[TBL] [Abstract][Full Text] [Related]
15. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
[TBL] [Abstract][Full Text] [Related]
18. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice.
Mai Z; Blackburn GL; Zhou JR
Carcinogenesis; 2007 Jun; 28(6):1217-23. PubMed ID: 17234721
[TBL] [Abstract][Full Text] [Related]
19. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.
Ju YH; Doerge DR; Allred KF; Allred CD; Helferich WG
Cancer Res; 2002 May; 62(9):2474-7. PubMed ID: 11980635
[TBL] [Abstract][Full Text] [Related]
20. Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Khuroo T; Verma D; Talegaonkar S; Padhi S; Panda AK; Iqbal Z
Int J Pharm; 2014 Oct; 473(1-2):384-94. PubMed ID: 25051112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]